Seattle Biotech Lumen Bioscience Raises $30M Series C Extension, Adds Microsoft Vet Jeff Raikes to Board

Seattle biotech startup Lumen Bioscience raised a $30 million Series C extension led by WestRiver Group, bringing total funding to $186.8 million to advance its oral biologic drugs. The company also added Microsoft veteran Jeff Raikes to its board and announced several leadership updates.

JJeff Raikes LLumen Biosciences